Hapni facilitates the prevention, diagnosis and treatment of sleep apnea.
Hapni has raised €2.0M across 1 funding round from 1 investor, most recently a round in Mar 2023. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-14 | Other | €2.0M |
| Otium Capital |
| View deal → |
